Active Filter(s):
Details:
MP101 is a once-daily, oral brain penetrant mitochondrial stimulator, that improves central nervous system survival and function. It is under phase 1/2 clinical development for the treatment of amyotrophic lateral sclerosis, multiple sclerosis & huntington’s disease.
Lead Product(s): MP101
Therapeutic Area: Neurology Product Name: MP101
Highest Development Status: Phase I/ Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 09, 2024